Amylin receptor subunit interactions are modulated by agonists and determine signaling
Science Signaling · 2025
DOI: 10.1126/scisignal.adt8127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Sandra E Gostynska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Hauptthemen laut MEDLINE: Signal Transduction, Receptors, Islet Amyloid Polypeptide, Amylin Receptor Agonists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Three amylin receptors (AMYRs) mediate the metabolic actions of the peptide hormone amylin and are drug targets for diabetes and obesity. AMY 1 R, AMY 2 R, and AMY 3 R are heterodimers consisting of the calcitonin receptor (CTR), a G protein–coupled receptor, paired with a RAMP1, RAMP2, or RAMP3 accessory subunit, respectively, which increases amylin potency. Here, we found that the AMYRs had distinct basal subunit equilibria that were modulated by peptide agonists and determined the extent of cAMP signaling downstream of receptor activation. By developing a biochemical assay that resolves the AMYR heterodimers and free subunits, we found that the AMY 1 R and AMY 2 R subunit distributions favored free CTR and RAMPs and that rat amylin promoted association of the constituent subunits of AMY 1 R and AMY 2 R. The agonist αCGRP also induced AMY 1 R subunit association. A stronger interaction between the CTR and the RAMP3 transmembrane domains yielded a more stable AMY 3 R, and human and salmon calcitonin agonists promoted AMY 3 R dissociation. Similar changes in subunit association and dissociation were observed in live-cell membranes, and G protein coupling and cAMP signaling assays showed how these changes altered signaling. Our findings have implications for AMYR biology and drug development and reveal regulation of heteromeric GPCR signaling through subunit interaction dynamics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
- Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
- Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.
- Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta, GA 30912, USA.
ORCID-Profile: Sandra E Gostynska, Jordan A Karim, Peyton H Gordon, Katie M Babin, Asuka Inoue, Nevin A Lambert, Augen A Pioszak
Förderung
- NIGMS NIH HHS
Zitieren
APA
Gostynska, S. E., Karim, J. A., Ford, B. E., Gordon, P. H., Babin, K. M., Inoue, A., Lambert, N. A., & Pioszak, A. A. (2025). Amylin receptor subunit interactions are modulated by agonists and determine signaling. Science Signaling. https://doi.org/10.1126/scisignal.adt8127
Vancouver
Gostynska SE, Karim JA, Ford BE, Gordon PH, Babin KM, Inoue A, et al. Amylin receptor subunit interactions are modulated by agonists and determine signaling. Science Signaling. 2025. doi:10.1126/scisignal.adt8127
BibTeX
@article{Gostynska2025,
author = {Gostynska, Sandra E and Karim, Jordan A and Ford, Bailee E and Gordon, Peyton H and Babin, Katie M and Inoue, Asuka and Lambert, Nevin A and Pioszak, Augen A},
title = {Amylin receptor subunit interactions are modulated by agonists and determine signaling},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adt8127}
}
EUVIMED